A Phase II, fixed-sequenced, open- label, research study to assess pharmacokinetic drug interactions of AEGR-733 on lipid-lowering therapies in healthy volunteers.

Trial Profile

A Phase II, fixed-sequenced, open- label, research study to assess pharmacokinetic drug interactions of AEGR-733 on lipid-lowering therapies in healthy volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2015

At a glance

  • Drugs Lomitapide (Primary) ; Atorvastatin; Dextromethorphan; Ezetimibe; Fenofibrate; Niacin; Simvastatin
  • Indications Hyperlipoproteinaemia type IIa
  • Focus Pharmacokinetics
  • Sponsors Aegerion Pharmaceuticals
  • Most Recent Events

    • 13 Oct 2009 Actual patient number (125) added as reported by ClinicalTrials.gov.
    • 13 Oct 2009 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
    • 07 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top